Bagust A, Beale S. Deteriorating beta-cell function in type 2 diabetes: a long-term model. QJM. 2003;96(4):281–8 https://doi.org/10.1093/qjmed/hcg040.
Article
CAS
PubMed
Google Scholar
Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N, et al. Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: the Japan diabetes complication and its prevention prospective study 3 (JDCP study 3). J Diabetes Investig. 2017;8(2):243–9 https://doi.org/10.1111/jdi.12550.
Article
CAS
PubMed
Google Scholar
Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355(23):2427–43 https://doi.org/10.1056/NEJMoa066224.
Article
CAS
PubMed
Google Scholar
Fang M, Echouffo-Tcheugui JB, Selvin E. Clinical and public health implications of 2019 Endocrine Society guidelines for diagnosis of diabetes in older adults. Diabetes Care. 2020;43(7):1456–61 https://doi.org/10.2337/dc19-2467.
Article
PubMed
PubMed Central
Google Scholar
Jung CH, Son JW, Kang S, Kim WJ, Kim HS, Kim HS, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J. 2021;45(1):1–10 https://doi.org/10.4093/dmj.2020.0254.
Article
PubMed
PubMed Central
Google Scholar
Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–8 https://doi.org/10.1001/jamainternmed.2013.12956.
Article
PubMed
PubMed Central
Google Scholar
Del Prato S, Foley JE, Kothny W, Kozlovski P, Stumvoll M, Paldanius PM, et al. Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial. Diabet Med. 2014;31(10):1178–84 https://doi.org/10.1111/dme.12508.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mamo Y, Bekele F, Nigussie T, Zewudie A. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University medical center, Jimma zone, south West Ethiopia: a case control study. BMC Endocr Disord. 2019;19(1):91 https://doi.org/10.1186/s12902-019-0421-0.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim YG, Park DG, Moon SY, Jeon JY, Kim HJ, Kim DJ, et al. Hypoglycemia and dementia risk in older patients with type 2 diabetes mellitus: a propensity-score matched analysis of a population-based cohort study. Diabetes Metab J. 2020;44(1):125–33 https://doi.org/10.4093/dmj.2018.0260.
Article
PubMed
Google Scholar
Dziedzic B, Sienkiewicz Z, Lenczuk-Gruba A, Kobos E, Fidecki W, Wysokiski M. Prevalence of Depressive Symptoms in the Elderly Population Diagnosed with Type 2 Diabetes Mellitus. Int J Environ Res Public Health. 2020;17(10). https://doi.org/10.3390/ijerph17103553.
Lee PG, Halter JB. The pathophysiology of hyperglycemia in older adults: clinical considerations. Diabetes Care. 2017;40(4):444–52 https://doi.org/10.2337/dc16-1732.
Article
PubMed
Google Scholar
American DA. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615 https://doi.org/10.2337/dc08-9017.
Article
Google Scholar
Aguayo-Mazzucato C, Andle J, Lee TB Jr, Midha A, Talemal L, Chipashvili V, et al. Acceleration of beta cell aging determines diabetes and Senolysis improves disease outcomes. Cell Metab. 2019;30(1):129–42 e4 https://doi.org/10.1016/j.cmet.2019.05.006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koo BK, Roh E, Yang YS, Moon MK. Difference between old and young adults in contribution of beta-cell function and sarcopenia in developing diabetes mellitus. J Diabetes Investig. 2016;7(2):233–40 https://doi.org/10.1111/jdi.12392.
Article
PubMed
Google Scholar
Sugimoto K, Tabara Y, Ikegami H, Takata Y, Kamide K, Ikezoe T, et al. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Investig. 2019;10(6):1471–9 https://doi.org/10.1111/jdi.13070.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, et al. 2019 clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes Metab J. 2019;43(4):398–406 https://doi.org/10.4093/dmj.2019.0137.
Article
PubMed
PubMed Central
Google Scholar
American DA. 12. Older adults: standards of medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S168–S79 https://doi.org/10.2337/dc21-S012.
Article
Google Scholar
Wu D, Li L, Liu C. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Obes Metab. 2014;16(1):30–7 https://doi.org/10.1111/dom.12174.
Article
CAS
PubMed
Google Scholar
Wang B, Sun Y, Sang Y, Liu X, Liang J. Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: a system review and meta-analysis. Medicine (Baltimore). 2018;97(46):e12633 https://doi.org/10.1097/MD.0000000000012633.
Article
CAS
Google Scholar
Cho YK, Kang YM, Lee SE, Lee J, Park JY, Lee WJ, et al. Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2018;44(5):393–401 https://doi.org/10.1016/j.diabet.2018.01.011.
Article
CAS
PubMed
Google Scholar
Wang N, Yang T, Li J, Zhang X. Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Metab Syndr Obes. 2019;12:1513–26 https://doi.org/10.2147/DMSO.S202024.
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010;1(2):36–47 https://doi.org/10.4239/wjd.v1.i2.36.
Article
PubMed
PubMed Central
Google Scholar
Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32(12):2297–9 https://doi.org/10.2337/dc09-0574.
Article
PubMed
PubMed Central
Google Scholar
Pacific WHOROftW. The Asia-Pacific perspective : redefining obesity and its treatment: Australia : health communications Australia; 2000.
Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee SS, et al. Obesity fact sheet in Korea, 2019: prevalence of obesity and abdominal obesity from 2009 to 2018 and social factors. J Obes Metab Syndr. 2020;29(2):124–32 https://doi.org/10.7570/jomes20058.
Article
PubMed
PubMed Central
Google Scholar
Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109(23):2818–25 https://doi.org/10.1161/01.CIR.0000132467.45278.59.
Article
CAS
PubMed
Google Scholar
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.
Article
CAS
PubMed
Google Scholar
Koo BK. The differential association between muscle strength and diabetes mellitus according to the presence or absence of obesity. J Obes Metab Syndr. 2019;28(1):46–52 https://doi.org/10.7570/jomes.2019.28.1.46.
Article
PubMed
PubMed Central
Google Scholar
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31 https://doi.org/10.1093/ageing/afy169.
Article
PubMed
Google Scholar
Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30(6):1507–12 https://doi.org/10.2337/dc06-2537.
Article
PubMed
Google Scholar
Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40(2):140–6 https://doi.org/10.4093/dmj.2016.40.2.140.
Article
PubMed
PubMed Central
Google Scholar
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–46 https://doi.org/10.1016/s0140-6736(19)31138-9.
Article
PubMed
Google Scholar
Kunutsor SK, Isiozor NM, Khan H, Laukkanen JA. Handgrip strength-a risk indicator for type 2 diabetes: systematic review and meta-analysis of observational cohort studies. Diabetes Metab Res Rev. 2021;37(2):e3365 https://doi.org/10.1002/dmrr.3365.
Article
CAS
PubMed
Google Scholar
Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY. Greater hand-grip strength predicts a lower risk of developing type 2 diabetes over 10 years in leaner Japanese Americans. Diabetes Res Clin Pract. 2011;92(2):261–4 https://doi.org/10.1016/j.diabres.2011.01.007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee J, Kim D, Kim C. Resistance training for glycemic control, muscular strength, and lean body mass in old type 2 diabetic patients: a Meta-analysis. Diabetes Ther. 2017;8(3):459–73 https://doi.org/10.1007/s13300-017-0258-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Artero EG. Lee D-c, Lavie CJ, España-Romero V, sui X, church TS, et al. effects of muscular strength on cardiovascular risk factors and prognosis. Journal of Cardiopulmonary Rehabilitation and Prevention. 2012;32(6):351–8 https://doi.org/10.1097/HCR.0b013e3182642688.
Article
PubMed
PubMed Central
Google Scholar
Koo BK, Moon MK. Are we in the same risk of diabetes mellitus? Gender- and age-specific epidemiology of diabetes in 2001 to 2014 in the Korean population. Diabetes Metab J. 2016;40(3):175–81 https://doi.org/10.4093/dmj.2016.40.3.175.
Article
PubMed
PubMed Central
Google Scholar
Koo BK, Kim SW, Yi KH, Park KS, Moon MK. Changing relative contribution of abdominal obesity and a family history of diabetes on prevalence of diabetes mellitus in Korean men and women aged 30-49 years from 2001 to 2010. J Diabetes. 2015;7(4):465–72 https://doi.org/10.1111/1753-0407.12202.
Article
PubMed
Google Scholar
Fasanmade OA, Okubadejo NU. Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus. Niger J Clin Pract. 2007;10(1):52–7.
CAS
PubMed
Google Scholar
Koo BK, Kim SW, Yi KH, Moon MK. Low economic status is identified as an emerging risk factor for diabetes mellitus in korean men aged 30 to 59 years in korean national health and nutrition examination survey 2008 to 2010. Diabetes Metab J. 2015;39(2):137–46 https://doi.org/10.4093/dmj.2015.39.2.137.
Article
PubMed
PubMed Central
Google Scholar
Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260 https://doi.org/10.3389/fphys.2012.00260.
Article
PubMed
PubMed Central
Google Scholar
Kang S, Oh TJ, Cho BL, Park YS, Roh E, Kim HJ, et al. Sex differences in sarcopenia and frailty among community-dwelling Korean older adults with diabetes: the Korean frailty and aging cohort study. J Diabetes Investig. 2021;12(2):155–64 https://doi.org/10.1111/jdi.13348.
Article
CAS
PubMed
Google Scholar
de Freitas MM, de Oliveira VLP, Grassi T, Valduga K, Miller MEP, Schuchmann RA, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol. 2020;132:110835 https://doi.org/10.1016/j.exger.2020.110835.
Article
PubMed
Google Scholar
Fukuoka Y, Narita T, Fujita H, Morii T, Sato T, Sassa MH, et al. Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients. J Diabetes Investig. 2019;10(2):322–30 https://doi.org/10.1111/jdi.12908.
Article
CAS
PubMed
Google Scholar
Chen F, Xu S, Wang Y, Chen F, Cao L, Liu T, et al. Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin. J Diabetes Res. 2020;2020:3950404 https://doi.org/10.1155/2020/3950404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gunasekaran U, Gannon M. Type 2 diabetes and the aging pancreatic beta cell. Aging (Albany NY). 2011;3(6):565–75. https://doi.org/10.18632/aging.100350.
Article
CAS
Google Scholar
Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study. J Am Med Dir Assoc. 2021;22(4):834–8 e1 https://doi.org/10.1016/j.jamda.2020.11.003.
Article
PubMed
Google Scholar
Yang YS, Kwak SH, Park KS. Update on monogenic diabetes in Korea. Diabetes Metab J. 2020;44(5):627–39 https://doi.org/10.4093/dmj.2020.0214.
Article
PubMed
PubMed Central
Google Scholar
Yamamoto S, Hotta K, Ota E, Mori R, Matsunaga A. Effects of resistance training on muscle strength, exercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: a meta-analysis. J Cardiol. 2016;68(2):125–34 https://doi.org/10.1016/j.jjcc.2015.09.005.
Article
PubMed
Google Scholar
Liao W. Chen Jw, Chen X, Lin L, Yan Hy, Zhou Yq, et al. impact of resistance training in subjects with COPD: a systematic review and Meta-analysis. Respir Care. 2015;60(8):1130–45 https://doi.org/10.4187/respcare.03598.
Article
PubMed
Google Scholar